Pharmacokinetics of pimobendan after oral administration to dogs with myxomatous mitral valve disease

BACKGROUND: Pimobendan is an important therapy for dogs with myxomatous mitral valve disease (MMVD). The pharmacokinetics are reported in healthy dogs but not in dogs with heart disease. HYPOTHESIS/OBJECTIVES: To determine if dog characteristics such as age, breed, body condition score, ACVIM stage...

Descripción completa

Detalles Bibliográficos
Autores principales: McManamey, Anna K., DeFrancesco, Teresa C., Meurs, Kathryn M., Papich, Mark G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2023
Materias:
SMALL ANIMAL
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10658550/
https://www.ncbi.nlm.nih.gov/pubmed/37776546
http://dx.doi.org/10.1111/jvim.16891

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10658550/
https://www.ncbi.nlm.nih.gov/pubmed/37776546
http://dx.doi.org/10.1111/jvim.16891

Ejemplares similares